A hormetic response model for glutamine stress in cancer

Area of Science:

• Oncology
• Cancer Metabolism
• Cellular Biology

Background:

• Glutamine metabolism is crucial for cancer development and progression.
• Current glutamine metabolism inhibitors show limited clinical success.
• Cancer cells exhibit stress responses to glutamine targeting.

Purpose of the Study:

• To propose a new model for understanding cancer cell responses to glutamine metabolism inhibition.
• To guide future research towards more effective cancer therapies.
• To address the limited clinical benefit of current glutamine-targeting strategies.

Main Methods:

• Review of clinical studies on glutamine metabolism inhibitors.
• Analysis of preclinical investigations into cancer cell stress responses.
• Conceptual modeling of cellular responses as a biphasic hormetic effect.

Main Results:

• Glutamine deprivation or targeting can induce biphasic hormetic responses in cancer cells.
• Existing therapeutic strategies may not fully account for these adaptive mechanisms.
• A deeper understanding of hormesis is needed for effective cancer treatment.

Conclusions:

• A biphasic hormetic response model can explain observed outcomes of glutamine metabolism inhibition.
• Future cancer therapies should anticipate and counteract hormetic effects.
• Co-targeting cancer adaptive mechanisms alongside glutamine metabolism is essential for clinical efficacy.